Tecan Group AG (LON:0QLN)
London · Delayed Price · Currency is GBP · Price in CHF | Market Cap | 1.60B -6.6% |
| Revenue (ttm) | 826.89M -5.5% |
| Net Income | -103.68M |
| EPS | -8.19 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 22.25 |
| Dividend | 2.84 (2.15%) |
| Ex-Dividend Date | Apr 17, 2026 |
| Volume | 10,050 |
| Average Volume | 17,672 |
| Open | 135.30 |
| Previous Close | 134.70 |
| Day's Range | 133.20 - 137.00 |
| 52-Week Range | 111.00 - 177.55 |
| Beta | 1.01 |
| RSI | 57.81 |
| Earnings Date | Aug 11, 2026 |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has ... [Read more]
News
Tecan price target lowered to CHF 138 from CHF 148 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Tecan (TCHBF) to CHF 138 from CHF 148 and keeps a Hold rating on the shares.
Tecan price target lowered to CHF 136 from CHF 137 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Tecan (TCHBF) to CHF 136 from CHF 137 and keeps an Equal Weight rating on the shares.
Tecan price target lowered to CHF 148 from CHF 165 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Tecan (TCHBF) to CHF 148 from CHF 165 and keeps a Hold rating on the shares.
Tecan price target lowered to CHF 137 from CHF 142 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Tecan (TCHBF) to CHF 137 from CHF 142 and keeps an Equal Weight rating on the shares.
Tecan upgraded to Market Perform from Underperform at Bernstein
Bernstein upgraded Tecan (TCHBF) to Market Perform from Underperform with a CHF 156 price target The firm says the company is now better positioned for a recovery in life sciences…
Tecan price target raised to CHF 205 from CHF 200 at Berenberg
Berenberg analyst Harry Gillis raised the firm’s price target on Tecan (TCHBF) to CHF 205 from CHF 200 and keeps a Buy rating on the shares.
Tecan price target lowered to CHF 142 from CHF 160 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Tecan (TCHBF) to CHF 142 from CHF 160 and keeps an Equal Weight rating on the shares.
Tecan price target lowered to CHF 165 from CHF 170 at Deutsche Bank
Deutsche Bank analyst Jan Koch lowered the firm’s price target on Tecan (TCHBF) to CHF 165 from CHF 170 and keeps a Hold rating on the shares. Published first on…
Tecan price target lowered to CHF 170 from CHF 177 at Deutsche Bank
Deutsche Bank analyst Jan Koch lowered the firm’s price target on Tecan (TCHBF) to CHF 170 from CHF 177 and keeps a Hold rating on the shares. Published first on…
Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confirms full-year 2025 outlook
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confir...
Tecan price target lowered to CHF 177 from CHF 190 at Deutsche Bank
Deutsche Bank analyst Jan Koch lowered the firm’s price target on Tecan (TCHBF) to CHF 177 from CHF 190 and keeps a Hold rating on the shares. Published first on…
Tecan price target lowered to CHF 210 from CHF 220 at Berenberg
Berenberg lowered the firm’s price target on Tecan (TCHBF) to CHF 210 from CHF 220 and keeps a Buy rating on the shares.
Tecan price target lowered to CHF 168 from CHF 176 at Morgan Stanley
Morgan Stanley analyst Aisyah Noor lowered the firm’s price target on Tecan (TCHBF) to CHF 168 from CHF 176 and keeps an Equal Weight rating on the shares. Published first…
Tecan price target lowered to CHF 190 from CHF 197 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Tecan (TCHBF) to CHF 190 from CHF 197 and keeps a Hold rating on the shares, telling investors that the firm anticipate…
Tecan price target lowered to CHF 176 from CHF 188 at Morgan Stanley
Morgan Stanley analyst Aisyah Noor lowered the firm’s price target on Tecan (TCHBF) to CHF 176 from CHF 188 and keeps an Equal Weight rating on the shares. Published first…
Tecan initiated with an Underperform at Bernstein
Bernstein analyst Delphine Le Louet initiated coverage of Tecan (TCHBF) with an Underperform rating and CHF 165.20 price target The firm notes Tecan is a global leader in laboratory automation…
Tecan initiated with a Buy at Berenberg
Berenberg analyst Harry Gillis initiated coverage of Tecan (TCHBF) with a Buy rating and CHF 220 price target Tecan is a high-quality Swiss provider of life sciences and diagnostic lab…
Tecan price target lowered to CHF 197 from CHF 219 at Deutsche Bank
Deutsche Bank analyst Jan Koch lowered the firm’s price target on Tecan (TCHBF) to CHF 197 from CHF 219 and keeps a Hold rating on the shares. Published first on…
Tecan price target lowered to CHF 188 from CHF 192 at Morgan Stanley
Morgan Stanley analyst Aisyah Noor lowered the firm’s price target on Tecan (TCHBF) to CHF 188 from CHF 192 and keeps an Equal Weight rating on the shares. Published first…
Tecan price target lowered to CHF 192 from CHF 230 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Tecan (TCHBF) to CHF 192 from CHF 230 and keeps an Equal Weight rating on the shares.
Tecan price target lowered to CHF 219 from CHF 225 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Tecan (TCHBF) to CHF 219 from CHF 225 and keeps a Hold rating on the shares.